These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 1180118

  • 1. Diffusible fraction of cholesterol in serum of patients with nephrotic syndrome.
    Markiewicz K, Lutz W, Walasek L.
    Acta Med Pol; 1975; 16(3):151-8. PubMed ID: 1180118
    [No Abstract] [Full Text] [Related]

  • 2. Serum cholesterol and triglycerides in childhood nephrotic syndrome in northern Nigeria. A preliminary report.
    Abdurrahman MB, Suvarnabai PC, Aikhionbare HA, Timoszyk J.
    Trop Geogr Med; 1984 Mar; 36(1):7-11. PubMed ID: 6729984
    [Abstract] [Full Text] [Related]

  • 3. High-density lipoproteins in untreated idiopathic nephrotic syndrome without renal failure.
    Joven J, Rubiés-Prat J, Espinel E, Ras MR, Piera L.
    Nephrol Dial Transplant; 1987 Mar; 2(3):149-53. PubMed ID: 3114674
    [Abstract] [Full Text] [Related]

  • 4. Dietary cholesterol induced changes in lipid profile in patients with nephrotic syndrome and chronic renal failure.
    Jain PK, Arora RC, Agarwal N, Garg RK, Arora S, Gurbaxani RK, Sharma D.
    J Assoc Physicians India; 1991 Oct; 39(10):751-3. PubMed ID: 1816199
    [Abstract] [Full Text] [Related]

  • 5. [Hyperphosphatidemia and hypercoagulatility in nephrotic syndrome].
    Jipp P, Arkenau C, Ravens KG, Bruhn HD.
    Verh Dtsch Ges Inn Med; 1973 Oct; 79():698-700. PubMed ID: 4789946
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J, Bar-On H, Shafrir E.
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [Abstract] [Full Text] [Related]

  • 9. [Study of the fatty acids of the blood during nephrotic syndromes].
    Warembourg H, Biserte G, Bertrand M, Jaillard J, Sézille G.
    J Urol Nephrol (Paris); 1967 Nov; 73(4):286-95. PubMed ID: 6057516
    [No Abstract] [Full Text] [Related]

  • 10. Serum-cholesterol-binding reserve in patients with the nephrotic syndrome.
    Perez GO, Levine S, Gomez E, Hsia SL.
    Nephron; 1979 Nov; 24(3):146-9. PubMed ID: 492425
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lipid abnormalities in renal disease.
    Simon NM, Del Greco F.
    Ann Clin Lab Sci (1971); 1972 Nov; 2(3):186-90. PubMed ID: 4343276
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients.
    Wanner C, Krämer-Guth A, Nauck M, Quaschning T, Pavenstädt H, Schollmeyer P.
    Miner Electrolyte Metab; 1996 Nov; 22(1-3):39-46. PubMed ID: 8676822
    [Abstract] [Full Text] [Related]

  • 17. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN, Tvorogova MG, Levitova EN, Krylova EA.
    Vopr Med Khim; 1983 Nov; 29(2):17-23. PubMed ID: 6858031
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Behaviour of fibrinolysis in the nephrotic syndrome.
    Cucuianu M, Manasia M, Spînu C, Mărcuşu C, Roman S, Comănescu A.
    Med Interne; 1988 Nov; 26(2):109-14. PubMed ID: 3133746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.